Guardant Health, Inc. (BMV:GH)

Guardant Health Statistics

Total Valuation

Guardant Health has a market cap or net worth of MXN 217.62 billion. The enterprise value is 233.50 billion.

Market Cap	217.62B
Enterprise Value	233.50B

Important Dates

The last earnings date was Wednesday, October 29, 2025.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	124.71M
Shares Outstanding	n/a
Shares Change (YoY)	+2.22%
Shares Change (QoQ)	+0.56%
Owned by Insiders (%)	3.91%
Owned by Institutions (%)	97.95%
Float	121.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.14
PB Ratio	-33.47
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-31.92
EV / Sales	13.94
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-48.55

Financial Position

The company has a current ratio of 3.50

Current Ratio	3.50
Quick Ratio	2.47
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-5.06
Interest Coverage	-131.57

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-19.64%
Return on Invested Capital (ROIC)	-24.56%
Return on Capital Employed (ROCE)	-42.54%
Revenue Per Employee	8.24M
Profits Per Employee	-3.64M
Employee Count	2,021
Asset Turnover	0.64
Inventory Turnover	4.02

Taxes

In the past 12 months, Guardant Health has paid 21.64 million in taxes.

Income Tax	21.64M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +113.71% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+113.71%
50-Day Moving Average	1,293.16
200-Day Moving Average	n/a
Relative Strength Index (RSI)	59.87
Average Volume (20 Days)	1,557

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.09

Income Statement

In the last 12 months, Guardant Health had revenue of MXN 16.56 billion and -7.31 billion in losses. Loss per share was -58.92.

Revenue	16.56B
Gross Profit	10.56B
Operating Income	-8.11B
Pretax Income	-7.29B
Net Income	-7.31B
EBITDA	-7.38B
EBIT	-8.11B
Loss Per Share	-58.92

Balance Sheet

The company has 8.63 billion in cash and 24.33 billion in debt, giving a net cash position of -15.70 billion.

Cash & Cash Equivalents	8.63B
Total Debt	24.33B
Net Cash	-15.70B
Net Cash Per Share	n/a
Equity (Book Value)	-6.50B
Book Value Per Share	-52.01
Working Capital	10.86B

Cash Flow

In the last 12 months, operating cash flow was -4.09 billion and capital expenditures -721.45 million, giving a free cash flow of -4.81 billion.

Operating Cash Flow	-4.09B
Capital Expenditures	-721.45M
Free Cash Flow	-4.81B
FCF Per Share	n/a

Margins

Gross margin is 63.76%, with operating and profit margins of -49.01% and -44.18%.

Gross Margin	63.76%
Operating Margin	-49.01%
Pretax Margin	-44.05%
Profit Margin	-44.18%
EBITDA Margin	-44.56%
EBIT Margin	-49.01%
FCF Margin	n/a

Dividends & Yields

Guardant Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.22%
Shareholder Yield	-2.22%
Earnings Yield	-3.36%
FCF Yield	-2.21%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Guardant Health has an Altman Z-Score of -1.08 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.08
Piotroski F-Score	4